F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Up 63.9% in August

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a significant increase in short interest in August. As of August 14th, there was short interest totaling 18,771 shares, an increase of 63.9% from the July 30th total of 11,453 shares. Approximately 0.7% of the shares of the stock are short sold. Based on an average daily volume of 3,579 shares, the days-to-cover ratio is presently 5.2 days.

Institutional Investors Weigh In On F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC boosted its stake in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,739 shares of the company’s stock after buying an additional 3,831 shares during the quarter. Hunter Associates Investment Management LLC owned approximately 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 as of its most recent SEC filing.

F/m Emerald Life Sciences Innovation ETF Stock Down 0.4%

NASDAQ LFSC traded down $0.17 on Monday, hitting $45.79. 4,439 shares of the company’s stock were exchanged, compared to its average volume of 4,648. The stock has a 50-day moving average of $46.08 and a 200-day moving average of $40.13. F/m Emerald Life Sciences Innovation ETF has a 52 week low of $27.67 and a 52 week high of $48.78.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.